Weak Statutory Earnings May Not Tell The Whole Story For Summerset Group Holdings (NZSE:SUM)
Mar 06
Have your own idea? Try our Stock Screener
New Zealand (NZX) Healthcare Sector Analysis
UpdatedMar 10, 2025
DataAggregated Company Financials
Companies14
- 7D-0.5%
- 3M-6.4%
- 1Y18.0%
- YTD-9.2%
Over the last 7 days, the Healthcare industry has remained flat, although notably Fisher & Paykel Healthcare gained 3.3%. As for the the longer term, the industry is up 18% over the past 12 months. As for the next few years, earnings are expected to grow by 23% per annum.
Sector Valuation and Performance
Has the New Zealand Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 11 Mar 2025 | NZ$33.6b | NZ$17.6b | NZ$660.5m | 16.9x | 50.9x | 1.9x |
| Thu, 06 Feb 2025 | NZ$35.5b | NZ$18.2b | NZ$734.3m | 14.8x | 48.3x | 1.9x |
| Sat, 04 Jan 2025 | NZ$37.1b | NZ$18.3b | NZ$729.4m | 13.2x | 50.9x | 2x |
| Mon, 02 Dec 2024 | NZ$37.1b | NZ$18.1b | NZ$733.0m | 14.1x | 50.6x | 2x |
| Wed, 30 Oct 2024 | NZ$37.2b | NZ$18.2b | NZ$966.4m | 20.1x | 38.5x | 2x |
| Fri, 27 Sep 2024 | NZ$36.6b | NZ$18.1b | NZ$964.4m | 19.6x | 37.9x | 2x |
| Sun, 25 Aug 2024 | NZ$36.2b | NZ$18.0b | NZ$987.9m | 20.6x | 36.7x | 2x |
| Tue, 23 Jul 2024 | NZ$33.2b | NZ$17.7b | NZ$977.6m | 18.2x | 34x | 1.9x |
| Thu, 20 Jun 2024 | NZ$30.6b | NZ$17.4b | NZ$962.8m | 17x | 31.7x | 1.8x |
| Sat, 18 May 2024 | NZ$30.4b | NZ$17.3b | NZ$1.3b | 22.6x | 23.7x | 1.8x |
| Mon, 15 Apr 2024 | NZ$29.7b | NZ$17.3b | NZ$1.3b | 24.2x | 23.1x | 1.7x |
| Wed, 13 Mar 2024 | NZ$28.9b | NZ$17.1b | NZ$1.3b | 25.2x | 22.6x | 1.7x |
| Fri, 09 Feb 2024 | NZ$30.1b | NZ$16.5b | NZ$1.1b | 18.6x | 26.7x | 1.8x |
| Sun, 07 Jan 2024 | NZ$29.4b | NZ$16.6b | NZ$1.1b | 23.4x | 26x | 1.8x |
| Tue, 05 Dec 2023 | NZ$28.5b | NZ$16.6b | NZ$1.1b | 23.4x | 25.2x | 1.7x |
| Thu, 02 Nov 2023 | NZ$27.3b | NZ$16.6b | NZ$1.1b | 24.9x | 24.6x | 1.6x |
| Sat, 30 Sep 2023 | NZ$27.9b | NZ$16.4b | NZ$1.1b | 28.7x | 25.2x | 1.7x |
| Mon, 28 Aug 2023 | NZ$28.8b | NZ$16.5b | NZ$1.1b | 28.9x | 26.3x | 1.7x |
| Wed, 26 Jul 2023 | NZ$30.5b | NZ$15.9b | NZ$1.1b | 29x | 28.4x | 1.9x |
| Fri, 23 Jun 2023 | NZ$30.0b | NZ$15.9b | NZ$1.1b | 29.2x | 27.8x | 1.9x |
| Sun, 21 May 2023 | NZ$32.4b | NZ$15.3b | NZ$1.6b | 18.8x | 20.5x | 2.1x |
| Tue, 18 Apr 2023 | NZ$32.1b | NZ$15.6b | NZ$1.6b | 18.8x | 20.2x | 2.1x |
| Thu, 16 Mar 2023 | NZ$30.8b | NZ$15.5b | NZ$1.6b | 18.8x | 19.5x | 2x |
| Sat, 11 Feb 2023 | NZ$31.3b | NZ$14.8b | NZ$1.7b | 18.7x | 18.4x | 2.1x |
| Mon, 09 Jan 2023 | NZ$29.5b | NZ$14.6b | NZ$1.7b | 20x | 17.3x | 2x |
| Wed, 07 Dec 2022 | NZ$30.0b | NZ$14.5b | NZ$1.7b | 21.6x | 17.7x | 2.1x |
| Fri, 04 Nov 2022 | NZ$27.7b | NZ$14.9b | NZ$1.9b | 17.6x | 14.4x | 1.9x |
| Sun, 02 Oct 2022 | NZ$27.3b | NZ$15.4b | NZ$1.9b | 16.7x | 14.1x | 1.8x |
| Tue, 30 Aug 2022 | NZ$28.3b | NZ$15.2b | NZ$1.9b | 18.2x | 14.6x | 1.9x |
| Thu, 28 Jul 2022 | NZ$29.1b | NZ$14.0b | NZ$2.1b | 19.8x | 14.1x | 2.1x |
| Sat, 25 Jun 2022 | NZ$28.6b | NZ$13.9b | NZ$2.1b | 19.3x | 13.9x | 2.1x |
| Mon, 23 May 2022 | NZ$30.2b | NZ$13.6b | NZ$2.1b | 24x | 14.3x | 2.2x |
| Wed, 20 Apr 2022 | NZ$31.3b | NZ$14.0b | NZ$2.0b | 24x | 15.5x | 2.2x |
| Fri, 18 Mar 2022 | NZ$33.7b | NZ$13.8b | NZ$2.0b | 24.1x | 16.8x | 2.4x |
Price to Earnings Ratio
16.8x
Current Industry PE
- Investors are optimistic on the New Zealander Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 50.9x which is higher than its 3-year average PE of 25.8x.
- The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 31% per year over the last three years.
- Meanwhile revenues for these companies have grown 8.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the New Zealand Healthcare sector?
| NZ Market | -1.99% | |
| Healthcare | -0.52% | |
| Medical Equipment | 1.23% | |
| Healthcare Services | -2.98% | |
| Pharma | -4.24% | |
| Biotech | -9.56% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 72.5x.
- Analysts are expecting annual earnings growth of 23.9%, which is higher than its past year's earnings decline of 31.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 24% over the next 5 years.
- This is better than its past earnings decline of 32% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 10.0% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FPH Fisher & Paykel Healthcare | NZ$35.03 | 3.3% +NZ$656.5m | 42.7% | PE115x | |
| TAH Third Age Health Services | NZ$3.20 | 1.3% +NZ$398.2k | 92.8% | PE16.9x | |
| RUA Rua Bioscience | NZ$0.028 | 3.7% +NZ$218.8k | -62.2% | PS5.8x |
